PROVIDER PROFILE · NPI 1689659021
Joel AbbottMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,289
Unique beneficiaries
—
Total services
96,998
Distinct HCPCS
22
Medicare payment
$1.1M
Peer benchmark
Total Medicare services vs. 73 Rheumatology providers in AL — top quintile (cohort median 5,906).
PRESCRIBING · PART D · 2024
Total Rx claims
8,132
Beneficiaries
—
Total drug cost
$2.1M
Distinct drugs
84
Brand share
27.5%
Top prescribed drugs
Hydrocodone/Acetaminophen697 claims
Hydroxychloroquine Sulfate623 claims
Methotrexate Sodium472 claims
Oxycodone Hcl/Acetaminophen465 claims
Duloxetine Hcl462 claims
QUALITY · MIPS · 2024
Final MIPS score
86.1
Quality
100.0
Cost
53.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.47%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
101
By payment type
Food and Beverage$2K
Top paying entities
Food and Beverage$2K
REFERRAL NETWORK
Where Joel Abbott's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 220 | 426 |
| SOLSTAS LAB PARTNERS GROUP LLC | 33 | 91 |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | 20 | 30 |
| AFFINITY HOSPITAL LLC | 13 | 25 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE